Stock listing
NYSE American:CANF Can-Fite BioPharma Ltd. Stock
US listing (NYSE American) of Can-Fite BioPharma Ltd. · home listing TASE:CANF
Follow Can-Fite BioPharma Ltd. into a list and get an email when it puts out news.
Share price · AMEX:CANF
$1.65 USD -0.13 (-7.3%)
Close on Oct 27, 2026
- Day range
- $1.64 – $1.71 USDOct 27, 2026
- Volume
- 77,863 sharesOct 27, 2026
- Market cap
- $5.00M USDAt the close on Oct 27, 2026 · price × 3.03M shares outstanding
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| TASE:CANF · Home | 257.00 ILA (agorot) | -12.40 (-4.6%) | 4,877 | 263.90 | 266.00 | 257.00 | 269.40 | Close on Oct 29, 2026 |
| NYSE American:CANF | $1.65 USD | -0.13 (-7.3%) | 77,863 | $1.65 | $1.71 | $1.635 | $1.78 | Close on Oct 27, 2026 |
- Ticker
- NYSE American:CANF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE American
- Currency
- USD
What changed lately
Calls
Replays
Can-Fite Biopharma (TASE:CANF) Q3 2020 Earnings Call
Mon, Nov 30, 2020 · 9:15 AM ET
Watch Transcript
Latest news
Decks
Investor Presentation (November 2025)
Investor deck · 29 slides · November 2025
Investor Presentation (February 2025)
Investor deck · 23 slides · Feb 5, 2025
Investor Presentation (September 2023)
Investor deck · 22 slides · Sep 7, 2023
Investor Presentation (March 2020)
Investor deck · 20 slides · Mar 9, 2020
Can-Fite BioPharma Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 19 in the last 12 months · 36 in all · newest Sep 8, 2026 · oldest 2025
- Calls
- 1 call with a replay · 1 with a transcript · latest Nov 30, 2020
- Decks
- 13 decks · latest November 2025
Where Can-Fite BioPharma Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| TASE:CANF · Home listing | TASE | Israel | ILA |
| NYSE American:CANF · This page | NYSE American | United States | USD |
| BOATS:CANF | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Can-Fite BioPharma Ltd.